Antithrombotic drugs are known as an agent which reduces the formation of thrombus or clot in the blood. A thrombus or clot is formed at the site of injuries, which can be a simple skin injury or the major intravascular injury. Normally it takes about 12-16 seconds to form the thrombus in normal conditions without use of any antithrombotic drugs. In the last decade, there have been substantial activities for research and development of new medications and drugs for treatment and prevention of complications by thrombotic drugs. There are two types of thrombosis – arterial thrombosis and venous thrombosis. This thrombosis can be treated with the use of antithrombotic drugs. The antithrombotic drugs are of three types which include thrombolytic drugs, antiplatelet drugs, and anticoagulants. An impressive number of antithrombotic drugs are introduced in the market in the recent past years as well as the prescription pattern for antithrombotic drugs in the medical practices is also increased extensively which drives the market growth. The major and branded antithrombotic drugs include Plavix, Pletal, Lovenox, Pradaxa, Xarelto, Effient, Activase, Aspirin and Cardio which contribute the leading shares in the global antithrombotic drugs market.
The global antithrombotic drugs market is anticipated to register a significant CAGR over a forecast period. The increasing prevalence of chronic diseases worldwide leads to the thrombotic diseases and require long-term drug administration of antithrombotic drugs, which is the major factor boost the demand for the antithrombotic drugs and drives the global antithrombotic drugs market. The unavailability of any specific substitute for the antithrombotic drugs also propel the use of antithrombotic drugs and drives the global antithrombotic drugs market. The many drugs which are used as antithrombotic drugs are off- patented, and many companies entered into the manufacturing of generic versions of the antithrombotic drugs, which also propel the growth of the antithrombotic drugs market. The increasing research and development activities for the new drug development and up-gradation in the antithrombotic drug as well as the new product launches in the recent few years to the global market, also drives the growth of the global antithrombotic drugs market.
Market: Key Players
Some of the major market players in of the global antithrombotic drugs market include Sanofi, Dr. Reddy’s Laboratories, Bayer AG, Boehringer Ingelheim GmbH, Genentech Inc., Eli Lilly and Company, Johnson & Johnson Services Inc., The Medicines Company, Pfizer Inc.
To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3206
The report covers exhaustive analysis on:
- Medical marijuana Market Segments
- Medical marijuana Market Dynamics
- Historical Actual Market Size, 2014 – 2016
- Medical marijuana Market Size & Forecast 2017 to 2025
- Medical marijuana Current Trends/Issues/Challenges
- Competition & Companies involved
- Medical marijuana Market Drivers and Restraints
Regional analysis includes
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3206
Antithrombotic Drugs Market
The global antithrombotic drugs market is segmented on the basis of types, indications and end use.
On the basis of types, the global antithrombotic drugs market is segmented into:
- Anticoagulant
- Antiplatelet
- Thrombolytic drugs
On the basis of indications, the global antithrombotic drugs market is segmented into:
- Acute coronary syndrome (ACS)
- Myocardial infarction (MI)
- Stroke
- Venous thromboembolism (VTE)
- Peripheral arterial occlusion (PAO)
- others
On the basis of end use, the global antithrombotic drugs market is segmented into:
- Thromboembolic disease treatment
- Prophylactic treatment
- Blood clot prevention
- Hyperlipidemia treatment
- Others
